ATAD2 and cancer: Since histone acetylation regulates transcriptional programs that determine cellular responses to therapy, cancer cells exploit epigenetic mechanisms, including ATAD2-mediated chromatin modulation, to evade cytotoxic effects [25,117,118,119,120,121].